SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

NCT01445392 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Mesothelioma

Interventions

BIOLOGICAL: Multicycle SS1P
DRUG: Pemetrexed
DRUG: Cisplatin
BIOLOGICAL: Single cycle SS1P

Sponsor

National Cancer Institute (NCI)